trending Market Intelligence /marketintelligence/en/news-insights/trending/ejwMjSDt7Qz4a-H8l0OVtw2 content esgSubNav
In This List

Flexion Therapeutics starts common stock offering

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Flexion Therapeutics starts common stock offering

Flexion Therapeutics Inc. started an underwritten public offering for 4 million common shares.

The specialty pharmaceutical company plans to grant underwriters an option to buy up to an additional 15% of the shares offered.

Net proceeds will be used to fund manufacturing and commercialization of company's drug Zilretta, product pipeline development, and for working capital and general corporate purposes.

Wells Fargo Securities, BMO Capital Markets and RBC Capital Markets are acting as joint book-running managers.